CTLA4 and bronchiolitis obliterans syndrome: Interestingly, it has been reported in a preclinical model of chronic lung allograft dysfunction that bronchiolitis obliterans can be attenuated by CTLA-4-Ig administration presumably by promoting LAG3+Treg mediated anti-inflammatory effects providing a potential mechanistic explanation for the observed clinical response [42].